AI-Driven Toolset for IPF and Aging Research Associates Lung Fibrosis with Accelerated Aging
Abstract
Idiopathic pulmonary fibrosis (IPF) is a condition predominantly affecting the elderly and leading to a decline in lung function. Our study investigates the aging-related mechanisms in IPF using artificial intelligence (AI) approaches. We developed a pathway-aware proteomic aging clock using UK Biobank data and applied it alongside a specialized version of Precious3GPT (ipf-P3GPT) to demonstrate an AI-driven mode of IPF research. The aging clock shows great performance in cross-validation (R2=0.84) and its utility is validated in an independent dataset to show that severe cases of COVID-19 are associated with an increased aging rate. Computational analysis using ipf-P3GPT revealed distinct but overlapping molecular signatures between aging and IPF, suggesting that IPF represents a dysregulation rather than mere acceleration of normal aging processes. Our findings establish novel connections between aging biology and IPF pathogenesis while demonstrating the potential of AI-guided approaches in therapeutic development for age-related diseases.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper investigates the mechanisms of idiopathic pulmonary fibrosis (IPF) in the context of aging, utilizing AI to explore the connections between aging biology and IPF pathogenesis. While it does not directly address the root causes of aging or lifespan extension, it provides insights into age-related diseases and their molecular underpinnings. The use of AI in this context is innovative, but the findings appear to be more of a solid contribution rather than a groundbreaking advance in the field of longevity research.
Author of this paper? Send a correction.